Pharma Industry News
BRISTOL, Tenn.--(BUSINESS WIRE)--Oct 13, 2008 - King Pharmaceuticals, Inc. (NYSE: KG) today announced that it is extending its previously announced tender offer for all outstanding shares of Class A Common Stock of Alpharma Inc. (NYSE: ALO) until...
Survey provides first estimates for HPV vaccination
WASHINGTON, Oct. 9, 2008--The nation's immunization coverage rates for preteens and teens are increasing for routinely recommended vaccines, but most still do not have all of the recommended...
NEW YORK--(BUSINESS WIRE)--Oct 9, 2008 - Omrix Biopharmaceuticals, Inc. ("Omrix") (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that the Fibrin Pad U.S....
ROCKVILLE, Md., Oct. 7, 2008--The FDA posted on its website a warning letter to BayerHealthCare Pharmaceuticals, Inc. regarding two 60 second DTC ads for oral contraceptive Yaz. According to the FDA, the ads, "are misleading because they...
Tiotropium (marketed as Spiriva HandiHaler)
Audience: Pulmonary care health professionals and patients
ROCKVILLE, Md., Oct. 7, 2008-FDA informed healthcare professionals that FDA has reviewed preliminary data from UPLIFT (Understanding the...
Anti-Cancer Drug Prevents, Reverses Cardiovascular Damage In Mouse Model Of Premature Aging Disorder
BETHESDA, Md., Oct. 7, 2008-An experimental anti-cancer drug can prevent -- and even reverse -- potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature...
Results published in New England Journal of Medicine reaffirm well-established efficacy and long-term safety profile of SPIRIVA(R) HandiHaler(R)
RIDGEFIELD, Conn., and NEW YORK, Oct. 5 /PRNewswire/ -- Results of the UPLIFT (Understanding Potential...
GENEVA, Switzerland, October 2/PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
WHITEHOUSE STATION, N.J., Oct. 2, 2008--(BUSINESS WIRE)--Merck & Co., Inc. will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for...
WASHINGTON, October 1, 2008— According to a new survey released by the National Consumers League (NCL) today, nearly three-quarters of prescription drug users would be very concerned if a drug they were prescribed was switched to another drug...
CORONA, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) , a leading specialty pharmaceutical company, today confirmed the receipt of a Paragraph IV Certification Notice Letter relating to an Abbreviated New Drug...
First-Line Chemotherapy Regimen Showed Clinically Relevant Survival Differences in Specific Histology Types of Advanced Non-Small Cell Lung Cancer
INDIANAPOLIS, Sept. 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE:LLY) announced today it...
ROCKVILLE, Md., Sept. 26, 2008-FDA has been made aware of preliminary safety findings from a clinical trial conducted in Germany investigating the use of epoetin alfa to treat acute ischemic stroke. The clinical trial utilized doses of epoetin alfa...
Cybercitizen® Health Europe Study Reveals the Tools European Consumers Use to Retrieve Health Information Online
NEW YORK, Sept. 26, 2008 – Search engines and Wikipedia play a major role in how European consumers retrieve health...
WASHINGTON, September 25, 2008 -According to a report released today by AARP, drug manufacturers have substantially raised prices on the 144 specialty drugs most commonly used by people in Medicare Part D.
The latest AARP Rx Watchdog Report, from...
LONDON, Sept. 22, 2008-The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Mental Health have today (24 September 2008) published a guideline on the diagnosis and management of attention deficit...
ROCKVILLE, Md., Sept. 23, 2008--The U.S. Food and Drug Administration (FDA) today announced that companies marketing unapproved ophthalmic balanced salt solutions (BSS) and unapproved topical drug products containing papain must stop manufacturing...
ROCKVILLE, Md., Sept. 23, 2008-OSI and Genentech notified healthcare professionals that cases of hepatic failure and hepatorenal syndrome, including fatalities, have been reported during use of Tarceva, particularly in patients with baseline hepatic...
SAN FRANCISCO, Sept. 23, 2008-Over half of all supporting trials for FDA-approved drugs remained unpublished 5 years after approval, says new research published in this week's PLoS Medicine. The most important trials determining efficacy, and those...
WILMINGTON, Del., September 22, 2008 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the United States Food and Drug Administration (FDA) has granted an additional six-month period of exclusivity to market CASODEX(R) (bicalutamide) for...
More...Pharma Industry News Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
